doi: 10.1016/j.jdermsci.2015.05.007 11 GerdesSMrowietzUBoehnckeWH
After knockdown of HrGSTm1 , compared with the control group, the mortality in the treatment group was increased by 16.7%, the average oviposition rate decreased by 33.9%, the average engorged body weight decreased by 287.38 mg and egg weight decreased by 127.46 mg, although only the engorged body weight was significantly different (t-test, t (44) = 2.886, P = 0.006)
As with any medication, GLP-1 drugs have potential risks and adverse effects that must be considered before initiating treatment
So I was scratching my head a little bit. The IJO paper was a retrospective cohort study of adults with obesity who had been prescribed a GLP-1 therapy, specifically Saxenda and Ozempic
The GLP-1 Nausea IV was built specifically for patients on semaglutide and tirzepatide medications